MoneyWorks4Me

Sanjivani Paranteral informs about outcome of board meeting

08 Apr 2024 Evaluate
Sanjivani Paranteral has informed that the Board of Directors of the Company at its Board Meeting held today 08th April 2024 considered and approved the following: Resignation of Hitesh Rajnikant Khona, Chief Financial Officer of the Company with effect from 08th April 2024 (Annexure 1); Resignation of Shrenikkumar Parasmalji Solanki, Independent Director of the Company with effect from 08th April 2024 (Annexure 2); Change in Designation of Srivardhan Ashwani Khemka (DIN: 08942106), from Non-Executive Director to Executive Director with effect from 08th April 2024 (Annexure 3); Appointment of Pritesh Jain as a Chief Financial Officer on the Board of the Company with effect from 08th April 2024 (Annexure 4); Appointment of Abhay Shah as an Additional Independent Director on the Board of the Company with effect from 08th April 2024 (Annexure 4).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..